SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                 SCHEDULE 13D/A

                   UNDER THE SECURITIES EXCHANGE ACT OF 1934

                               (Amendment No. 1)*


NAME OF ISSUER:  HEALTHRITE, INC.

TITLE OF CLASS OF SECURITIES:   Common Stock

CUSIP NUMBER:  42221F101000


NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO
RECEIVE NOTICES AND COMMUNICATIONS:

     Guy P. Lander, Esq., Rosenman & Colin, LLP
     211 Pennbrook Road, P. O. Box 97
     Far Hills, New Jersey 07931                 (908) 766-4101

DATE OF EVENT WHICH REQUIRES FILING:    December 29, 1999


If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule because of Rule 13d-1 (b)(3) or (4), check the following: ________

     Check the following if a fee is being paid with the statement:      (A fee
is not required only if the reporting  person:  (1) has a previous  statement on
file  reporting  beneficial  ownership of more than five percent of the class of
securities  described  in Item 1;  and (2) has  filed  no  amendment  subsequent
thereto reporting  beneficial  ownership of five percent or less of such class.)
(See Rule 13d-7.)

     Note: Six copies of this statement, including all exhibits, should be filed
with the  Commission.  See Rule 13d-1(a) for other parties to whom copies are to
be sent.

*The remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The  information  required on the remainder of this cover shall not be deemed to
be "filed" for the purpose of Section 18 of the Securities  Exchange Act of 1934
("Act") or otherwise  subject to the  liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).

                         (Continued on following pages)






CUSIP NO.:   42221F101000


1.       NAME OF REPORTING PERSON:   Pure World, Inc.

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
         (a)      (b)   XX

3.       [SEC USE ONLY]

4.       SOURCE OF FUNDS:  WC

5.       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
         PURSUANT TO ITEMS 2(d) OR 2(e):   YES          NO   XX

6.       CITIZENSHIP OR PLACE OF ORGANIZATION:   Delaware

7.       SOLE VOTING POWER:

8.       SHARED VOTING POWER:  313,200

9.       SOLE DISPOSITIVE POWER:  313,200

10.      SHARED DISPOSITIVE POWER:

11.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
         PERSON:   313,200

12.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
         CERTAIN SHARES:   YES           NO   XX

13.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):   5.67%

14.      TYPE OF REPORTING PERSON:   CO







Item 1.  SECURITY AND ISSUER

     This Amendment No. 1 relates to the Schedule 13D filed on August 3, 1998 in
connection with the ownership by Pure World,  Inc. ("Pure World") of shares,  no
par value ("Shares") of HealthRite,  Inc. ("HealthRite").  The capitalized terms
used in the Amendment,  unless otherwise defined, shall have the same meaning as
in the original Schedule 13D.

Item 3.  SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

     Item 3 is hereby amended by the addition of the following:

     Since the date of the last filing,  Pure World has sold in the open market,
86,800 Shares for proceeds of $27,914.43, net of any brokerage commissions.

Item 4. PURPOSE OF TRANSACTION.

     Item 4 is hereby amended by the addition of the following:

     In the future,  Pure World will  continue to buy or sell Shares as it deems
in its own best interest.

Item 5.  INTEREST  IN  SECURITIES  OF THE ISSUER.

     Item 5 is hereby amended by the addition of the following:

     (a)  As  of  the  close  of  business  on  January  19,  2000,  Pure  World
beneficially  owned 313,200 Shares,  representing  5.67% of the 5,524,531 Shares
reported as  outstanding  in  HealthRite's  Form  10-QSB for the  quarter  ended
September 30, 1999.



     (b) The  information  presented in Items 7 through 10 of the cover sheet to
this Schedule 13D is incorporated herein by reference.

     (c) Exhibit C annexed hereto sets forth all transactions in Shares effected
by Pure World in the sixty days  preceding  the date of this  Statement  and the
dates of such transactions.

Item 7.  MATERIAL TO BE FILED AS EXHIBITS.

         Exhibit C -  Transactions in Shares for the past 60 days






                                   SIGNATURE
                                   ---------


     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.


Dated: January 19, 2000


                                   PURE WORLD, INC.



                                   By:  /s/ John W. Galuchie, Jr.
                                      --------------------------------
                                      John W. Galuchie, Jr.
                                      Executive Vice President







                                   EXHIBIT C

                   Transactions in Shares for the Past 60 Days



                                   NUMBER OF                    PRICE
  DATE                            SHARES SOLD                 PER SHARE
- --------                    -------------------------      ------------------

12/02/1999                            2,500                    $.46875
12/23/1999                           10,000                     .1875
12/29/1999                           40,000                     .1875
01/19/2000                            2,500                     .6875